These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35704070)

  • 21. MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation.
    Maetani Y; Itoh K; Watanabe C; Shibata T; Ametani F; Yamabe H; Konishi J
    AJR Am J Roentgenol; 2001 Jun; 176(6):1499-507. PubMed ID: 11373220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression and prognostic value of soluble CD97 and its ligand CD55 in intrahepatic cholangiocarcinoma.
    Meng ZW; Liu MC; Hong HJ; Du Q; Chen YL
    Tumour Biol; 2017 Mar; 39(3):1010428317694319. PubMed ID: 28345461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mass-forming Intrahepatic Cholangiocarcinoma: Diffusion-weighted Imaging as a Preoperative Prognostic Marker.
    Lee J; Kim SH; Kang TW; Song KD; Choi D; Jang KT
    Radiology; 2016 Oct; 281(1):119-28. PubMed ID: 27115053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation of CT patterns of primary intrahepatic cholangiocarcinoma at the time of presentation with the metastatic spread and clinical outcomes: retrospective study of 92 patients.
    Baheti AD; Tirumani SH; Shinagare AB; Rosenthal MH; Hornick JL; Ramaiya NH; Wolpin BM
    Abdom Imaging; 2014 Dec; 39(6):1193-201. PubMed ID: 24869789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intrahepatic Mass-forming Cholangiocarcinoma: Arterial Enhancement Patterns at MRI and Prognosis.
    Min JH; Kim YK; Choi SY; Kang TW; Lee SJ; Kim JM; Ahn S; Cho H
    Radiology; 2019 Mar; 290(3):691-699. PubMed ID: 30620253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A proposal of imaging classification of intrahepatic mass-forming cholangiocarcinoma into ductal and parenchymal types: clinicopathologic significance.
    Rhee H; Kim MJ; Park YN; An C
    Eur Radiol; 2019 Jun; 29(6):3111-3121. PubMed ID: 30560357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benefit of radiotherapy for 90 patients with resected intrahepatic cholangiocarcinoma and concurrent lymph node metastases.
    Jiang W; Zeng ZC; Tang ZY; Fan J; Zhou J; Zeng MS; Zhang JY; Chen YX; Tan YS
    J Cancer Res Clin Oncol; 2010 Sep; 136(9):1323-31. PubMed ID: 20130909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gadoxetic acid enhanced magnetic resonance imaging for prediction of the postoperative prognosis of intrahepatic mass-forming cholangiocarcinoma.
    Kim S; An C; Han K; Kim MJ
    Abdom Radiol (NY); 2019 Jan; 44(1):110-121. PubMed ID: 30078083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of lymphadenectomy for long-term outcomes in node-negative intrahepatic cholangiocarcinoma: A multicenter study.
    Yoh T; Cauchy F; Le Roy B; Seo S; Taura K; Hobeika C; Dokmak S; Farges O; Gelli M; Sa Cunha A; Adam R; Uemoto S; Soubrane O
    Surgery; 2019 Dec; 166(6):975-982. PubMed ID: 31421869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relevance of suspicious lymph nodes in preoperative imaging for resectability, recurrence and survival of intrahepatic cholangiocarcinoma.
    Bartsch F; Hahn F; Müller L; Baumgart J; Hoppe-Lotichius M; Kloeckner R; Lang H
    BMC Surg; 2020 Apr; 20(1):75. PubMed ID: 32295646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does gross appearance indicate prognosis in intrahepatic cholangiocarcinoma?
    Yamamoto M; Takasaki K; Yoshikawa T; Ueno K; Nakano M
    J Surg Oncol; 1998 Nov; 69(3):162-7. PubMed ID: 9846503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum Angiopoietin-Like Protein 4: A Potential Prognostic Biomarker for Prediction of Vascular Invasion and Lymph Node Metastasis in Cholangiocarcinoma Patients.
    Aung TM; Ciin MN; Silsirivanit A; Jusakul A; Lert-Itthiporn W; Proungvitaya T; Roytrakul S; Proungvitaya S
    Front Public Health; 2022; 10():836985. PubMed ID: 35392474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognosis after resection for hepatitis B virus-associated intrahepatic cholangiocarcinoma.
    Wu ZF; Wu XY; Zhu N; Xu Z; Li WS; Zhang HB; Yang N; Yao XQ; Liu FK; Yang GS
    World J Gastroenterol; 2015 Jan; 21(3):935-43. PubMed ID: 25624728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intrahepatic and hilar mass-forming cholangiocarcinoma: Qualitative and quantitative evaluation with diffusion-weighted MR imaging.
    Fattach HE; Dohan A; Guerrache Y; Dautry R; Boudiaf M; Hoeffel C; Soyer P
    Eur J Radiol; 2015 Aug; 84(8):1444-1451. PubMed ID: 26022518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Value of diffusion-weighted MR imaging in the diagnosis of lymph node metastases in patients with cholangiocarcinoma.
    Holzapfel K; Gaa J; Schubert EC; Eiber M; Kleeff J; Rummeny EJ; Loos M
    Abdom Radiol (NY); 2016 Oct; 41(10):1937-41. PubMed ID: 27271285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A novel nomogram for individualized preoperative prediction of lymph node metastasis in patients with intrahepatic cholangiocarcinoma].
    Ma WH; Lei ZQ; Yu QS; Xiao QR; Tang HL; Si AF; Yang PH; Cheng ZJ
    Zhonghua Wai Ke Za Zhi; 2022 Apr; 60(4):363-371. PubMed ID: 35272428
    [No Abstract]   [Full Text] [Related]  

  • 37. Bone Metastases from Intrahepatic Cholangiocarcinoma Confer Worse Prognosis.
    Garajová I; Gelsomino F; Salati M; Leonardi F; De Lorenzo S; Granito A; Tovoli F
    Curr Oncol; 2023 Feb; 30(3):2613-2624. PubMed ID: 36975412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Routine lymph node dissection may be not suitable for all intrahepatic cholangiocarcinoma patients: results of a monocentric series.
    Li DY; Zhang HB; Yang N; Quan Y; Yang GS
    World J Gastroenterol; 2013 Dec; 19(47):9084-91. PubMed ID: 24379635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival.
    Ohtsuka M; Ito H; Kimura F; Shimizu H; Togawa A; Yoshidome H; Miyazaki M
    Br J Surg; 2002 Dec; 89(12):1525-31. PubMed ID: 12445060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes assessment in intrahepatic cholangiocarcinoma using qualitative and quantitative imaging features.
    King MJ; Hectors S; Lee KM; Omidele O; Babb JS; Schwartz M; Tabrizian P; Taouli B; Lewis S
    Cancer Imaging; 2020 Jul; 20(1):43. PubMed ID: 32620153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.